Short Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Drops By 48.2%

Posted by Scott Moore on Jun 14th, 2026

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) saw a large decline in short interest in the month of May. As of May 29th, there was short interest totaling 4,879 shares, a decline of 48.2% from the May 14th total of 9,417 shares. Based on an average daily volume of 5,501 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.5% of the shares of the company are sold short.

ProShares Ultra Nasdaq Biotechnology Stock Performance

Shares of NASDAQ:BIB traded up $0.55 on Friday, hitting $82.82. 5,456 shares of the company were exchanged, compared to its average volume of 10,542. The company’s 50 day moving average price is $82.76 and its two-hundred day moving average price is $82.45. ProShares Ultra Nasdaq Biotechnology has a one year low of $44.20 and a one year high of $90.90. The firm has a market capitalization of $77.02 million, a price-to-earnings ratio of 20.68 and a beta of 1.24.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Franklin Resources Inc. acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 2nd quarter valued at about $32,000. Citadel Advisors LLC acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 3rd quarter valued at about $307,000. Kaizen Financial Strategies acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 4th quarter valued at about $424,000. Finally, Palumbo Wealth Management LLC acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 3rd quarter valued at about $766,000.

ProShares Ultra Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.